Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases – PR Newswire
Lilly to buy Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases PR Newswire Source: news.google.com